Qatanani Mo, SVP and Head of Research, has demonstrated a clear selling bias in recent transactions involving Scholar Rock Holding Corporation (SRRK), the only company in which they have reported trades. According to SEC Form 4 filings, Mo has executed 29 transactions totaling $9.71 million in sales and $3.14 million in purchases—a nearly 3:1 ratio favoring disposals. The most significant sell-off occurred on December 4, 2025, with a single transaction valued at $6.17 million, dwarfing all other individual trades. Recent activity has been exclusively focused on divestment, with 12 sales since January 2026, including multiple transactions on February 23, 2026, ranging from $9,696 to $348,639.72, and a $371,713.79 sale on February 17.
Mo’s trading history shows sporadic buying activity earlier in the period, but the overwhelming trend since mid-2025 has been consistent selling. Smaller sales in July, September, and December 2025 preceded the accelerated disposals in early 2026, with January alone seeing four transactions exceeding $373,000 each. The absence of any recent acquisitions, coupled with the frequency and scale of sales, suggests a deliberate reduction in exposure to SRRK. While the filings include minor transactions coded as "M" (likely representing option exercises or other non-open-market activity), the dominant pattern remains the systematic liquidation of holdings in the biopharmaceutical firm.
AI-assisted summary